Foundayo is the fifth prescription drug to be authorized under the FDAs Commissioners National Priority Voucher program, through which the agency awards vouchers to drug developers whose work will address a health crisis in the United States, deliver more innovative cures, address unmet public health needs, and increase domestic drug manufacturing as a national security issue
Synthagen Laboratories NL-GHK-Cu in the prevention of common diseases such as, among others, arteriosclerosis, cataract, diabetes, nephropathy, and Alzheimers disease The therapy with the NL-GHK-Cu peptide, thanks to its antioxidant action, allows for the inhibition and prevention of many pathological phenomena related to the eye, neurodegenerative diseases, kidney diseases, and ailments of the cardiovascular system
Frequently asked questions Yes, L-Glutathione plays a crucial role in maintaining optimal immune function
High-dose vitamin C (1000-3000mg daily) is commonly recommended to complement injectable glutathione protocols
We want to be best in market, says Vinjamoori, the chief medical officer